Target intelligence / Profile preview

Immunoglobulin heavy variable 3-43 (IGHV3-43)

Target
IGHV3-43
Molecular classification
Immunoglobulin variable region, Antibody variable domain, Other
01

Overview

Immunoglobulin heavy variable 3-43 is a gene segment encoding the **variable domain** of the heavy chain in human immunoglobulins (antibodies)[1]. The protein, part of the immunoglobulin superfamily, contributes to antigen recognition by forming part of the antigen-binding site of antibodies, in conjunction with associated light chain variable domains[3]. The variable regions are generated through V-(D)-J recombination and provide the molecular diversity required for the adaptive humoral immune response[1][3]. The structure allows for high affinity binding to specific antigens, initiating B cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells[1][3]. IGHV3-43 is one among many IGHV germline gene segments, and the usage—or mutation status—of IGHV genes (in general, not specifically IGHV3-43) can serve as a diagnostic and prognostic biomarker in diseases such as chronic lymphocytic leukemia[2]. IGHV3-43 itself is not a typical direct therapeutic target (i.e., not a receptor, enzyme, or transporter), but rather a segment encoding antibody diversity for immune recognition[1][3].

Other names
Immunoglobulin heavy variable 3-43IGHV3-43IGHV343VHimmunoglobulin heavy chain variable region
02

Biological functions

Antigen bindingImmune response (immunoglobulin-mediated)Humoral immunity
03

Disease associations

Cancer (notably as a prognostic biomarker in chronic lymphocytic leukemia[2])InfectionOther (antibody response diversity in various diseases)
04

Biomarkers

Prognostic marker for chronic lymphocytic leukemia (through IGHV gene mutation status and gene usage[2])

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-43 (IGHV3-43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-43 (IGHV3-43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call